Robert C. Spiro

2.8k total citations · 1 hit paper
48 papers, 2.3k citations indexed

About

Robert C. Spiro is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Robert C. Spiro has authored 48 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Genetics. Recurrent topics in Robert C. Spiro's work include Glycosylation and Glycoproteins Research (17 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Proteoglycans and glycosaminoglycans research (9 papers). Robert C. Spiro is often cited by papers focused on Glycosylation and Glycoproteins Research (17 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Proteoglycans and glycosaminoglycans research (9 papers). Robert C. Spiro collaborates with scholars based in United States, Germany and Japan. Robert C. Spiro's co-authors include David A. Cheresh, Andrea Y. Thompson, James W. Poser, LinShu Liu, R. Reisfeld, Mohammad A. Heidaran, Hudson H. Freeze, Chunlin Yang, Minna Nokelainen and James Tang and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Robert C. Spiro

47 papers receiving 2.2k citations

Hit Papers

Biosynthetic and functional properties of an Arg-Gly-Asp-... 1987 2026 2000 2013 1987 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert C. Spiro United States 21 747 554 439 396 347 48 2.3k
David R. Olsen United States 27 774 1.0× 339 0.6× 430 1.0× 349 0.9× 201 0.6× 41 2.5k
Risto Penttinen Finland 26 977 1.3× 382 0.7× 473 1.1× 251 0.6× 508 1.5× 100 3.0k
Fumio Fukai Japan 25 704 0.9× 532 1.0× 277 0.6× 454 1.1× 441 1.3× 94 2.7k
G. Balian United States 18 526 0.7× 556 1.0× 312 0.7× 254 0.6× 488 1.4× 26 2.1k
M Hormia Finland 24 580 0.8× 450 0.8× 337 0.8× 351 0.9× 212 0.6× 42 1.9k
Erik Hedbom Switzerland 20 731 1.0× 523 0.9× 792 1.8× 215 0.5× 353 1.0× 26 2.4k
M Sandberg Finland 26 1.2k 1.5× 377 0.7× 297 0.7× 134 0.3× 321 0.9× 39 2.4k
J. Michael Sorrell United States 26 989 1.3× 327 0.6× 1.1k 2.5× 207 0.5× 359 1.0× 49 2.6k
Jayesh Dudhia United Kingdom 40 1.1k 1.4× 500 0.9× 750 1.7× 250 0.6× 1.3k 3.8× 103 4.5k
Jonathan A. Garlick United States 39 1.7k 2.3× 289 0.5× 714 1.6× 540 1.4× 488 1.4× 108 4.5k

Countries citing papers authored by Robert C. Spiro

Since Specialization
Citations

This map shows the geographic impact of Robert C. Spiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Spiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Spiro more than expected).

Fields of papers citing papers by Robert C. Spiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Spiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Spiro. The network helps show where Robert C. Spiro may publish in the future.

Co-authorship network of co-authors of Robert C. Spiro

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Spiro. A scholar is included among the top collaborators of Robert C. Spiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Spiro. Robert C. Spiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Spiro, Robert C., et al.. (2022). Effects of Titanium Implant Surface Topology on Bone Cell Attachment and Proliferation in vitro. Medical Devices Evidence and Research. Volume 15. 103–119. 20 indexed citations
4.
5.
Liu, LinShu, Joseph Kost, Fang Yan, & Robert C. Spiro. (2012). Hydrogels from Biopolymer Hybrid for Biomedical, Food, and Functional Food Applications. Polymers. 4(2). 997–1011. 72 indexed citations
6.
Yang, Chunlin, Patrick J. Hillas, Minna Nokelainen, et al.. (2004). The Application of Recombinant Human Collagen in Tissue Engineering. BioDrugs. 18(2). 103–119. 258 indexed citations
7.
Alini, Mauro, Wei Li, Paul Markovic, et al.. (2003). The Potential and Limitations of a Cell-Seeded Collagen/Hyaluronan Scaffold to Engineer an Intervertebral Disc-Like Matrix. Spine. 28(5). 446–453. 163 indexed citations
8.
Liu, LinShu, et al.. (2002). Hyaluronate‐heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF‐2). Journal of Biomedical Materials Research. 62(1). 128–135. 60 indexed citations
9.
Spiro, Robert C., Andrea Y. Thompson, & James W. Poser. (2001). Spinal fusion with recombinant human growth and differentiation factor‐5 combined with a mineralized collagen matrix. The Anatomical Record. 263(4). 388–395. 49 indexed citations
10.
Heidaran, Mohammad A., et al.. (2000). Extracellular Matrix Modulation of rhGDF-5-Induced Cellular Differentiation. 1(9). 121–135. 6 indexed citations
11.
Liu, LinShu, Andrea Y. Thompson, Mohammad A. Heidaran, James W. Poser, & Robert C. Spiro. (1999). An osteoconductive collagen/hyaluronate matrix for bone regeneration. Biomaterials. 20(12). 1097–1108. 134 indexed citations
12.
Radomsky, M., Andrea Y. Thompson, Robert C. Spiro, & James W. Poser. (1998). Potential Role of Fibroblast Growth Factor in Enhancement of Fracture Healing. Clinical Orthopaedics and Related Research. 355S(355 Suppl). S283–S293. 89 indexed citations
13.
Manzi, Adriana E., Paramahans V. Salimath, Robert C. Spiro, Paul A. Keifer, & Hudson H. Freeze. (1995). Identification of a Novel Glycosaminoglycan Core-like Molecule I. Journal of Biological Chemistry. 270(16). 9154–9163. 54 indexed citations
14.
Harper, John R., Robert C. Spiro, William A. Gaarde, et al.. (1994). [12] Role of transforming growth factor β and decorin in controlling fibrosis. Methods in enzymology on CD-ROM/Methods in enzymology. 245. 241–254. 31 indexed citations
15.
Wright, Kathryn E., Robert C. Spiro, John W. Burns, & Michael J. Buchmeier. (1990). Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus. Virology. 177(1). 175–183. 71 indexed citations
16.
Spiro, Robert C. & Vito Quaranta. (1989). The invariant chain is a phosphorylated subunit of class II molecules.. The Journal of Immunology. 143(8). 2589–2594. 20 indexed citations
17.
Spiro, Robert C., Willis G. Parsons, J P Caulfield, et al.. (1986). Inhibition of post-translational modification and surface expression of a melanoma-associated chondroitin sulfate proteoglycan by diethylcarbamazine or ammonium chloride.. Journal of Biological Chemistry. 261(11). 5121–5129. 21 indexed citations
19.
Sairenji, Takeshi, et al.. (1985). Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.. The Journal of Experimental Medicine. 161(5). 1097–1111. 12 indexed citations
20.
Howe, Rawleigh, et al.. (1979). Internal synthesis of p23,30 by several lymphoid malignancies.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 7(2). 94–104. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026